United States Neurosurgical Products Market Outlook to 2025

2.1 What Is This Report About?
2.2 Neurosurgical Products Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Neurosurgical Products Market, United States, Revenue ($m), 2015-2025
3.1.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Neurosurgical Products Market, United States, Volume (Units), 2015-2025
3.2.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Neurosurgical Products Market, United States, Average Price ($), 2015-2025
3.4 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2017

4.1 B. Braun Melsungen AG
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Stryker Corp
4.3.1 Company Overview
4.4 KARL STORZ GmbH & Co KG
4.4.1 Company Overview
4.5 DePuy Synthes Inc
4.5.1 Company Overview
4.6 Baxter International Inc
4.6.1 Company Overview
4.7 Integra LifeSciences Corp
4.7.1 Company Overview

6.1 Debt Offerings
6.1.1 Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028
6.2 Equity Offerings
6.2.1 Integra LifeSciences Prices Public Offering of Shares for USD307 Million
6.3 Partnerships
6.3.1 MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics
6.4 Private Equity
6.4.1 Shanghai Xianfeng Investment Management to Acquire Elliquence from Alan Ellman for USD77.1 Million
6.4.2 Sobera Capital Acquires Equity Holdings in 12 Pharma Companies
6.4.3 NeuroPace Raises USD74 Million in Equity Financing
6.5 Venture Financing
6.5.1 Myoscience Raises USD10 Million in Financing
6.5.2 Alcyone Lifesciences Raises USD5 Million in Venture Financing
6.5.3 MicroTransponder Raises USD11.6 Million in Venture Financing

7.1 Corporate Communications
7.1.1 Jul 10, 2018: Stryker announces organizational changes
7.1.2 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
7.1.3 Feb 19, 2018: FHC Promotes Melanie Cooper To Director Of Resources
7.1.4 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors
7.1.5 Jan 09, 2018: Kelyniam Global Announces Key Management Changes
7.1.6 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
7.1.7 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President - Research & Development
7.1.8 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan
7.2 Financial Announcements
7.2.1 Jul 18, 2018: Precipio announces 213% year-over-year revenue growth in preliminary Q2-2018 results
7.2.2 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results
7.2.3 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018
7.2.4 May 03, 2018: RTI Surgical Announces First Quarter 2018 Results
7.2.5 Apr 26, 2018: Stryker reports first quarter 2018 operating results
7.2.6 Mar 30, 2018: Vycor Medical Announces Financial Results for the Year Ended December 31st, 2017
7.2.7 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
7.2.8 Mar 01, 2018: RTI Surgical Announces Fourth Quarter and Full Year 2017 Results
7.2.9 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
7.2.10 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018
7.2.11 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
7.2.12 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
7.2.13 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
7.2.14 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result
7.2.15 Nov 13, 2017: Vycor Medical Reports Financial Results for the Three and Nine Months Ended September 30th, 2017
7.2.16 Nov 06, 2017: MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures
7.2.17 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018
7.2.18 Nov 02, 2017: RTI Surgical Announces 2017 Third Quarter Results
7.2.19 Oct 26, 2017: Stryker reports third quarter 2017 results
7.2.20 Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results
7.3 Government and Public Interest
7.3.1 Apr 03, 2018: Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
7.4 Legal And Regulatory
7.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital
7.5 Other Significant Developments
7.5.1 Jun 19, 2018: Cardinal Health Foundation Awards Over $3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia
7.5.2 Jun 12, 2018: IMRIS Continues to Expand Global Customer Service
7.5.3 Apr 04, 2018: RTI Surgical Reaches Global Milestone of Providing 8 Million Biologic Implants with Zero Confirmed Incidence of Implant-Associated Infection
7.5.4 Feb 22, 2018: Kelyniam Global Announces Multi-year Distribution Partnership
7.5.5 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017
7.5.6 Jan 05, 2018: RTI Surgical Outlines 2018 Guidance and Long-Term Goals
7.6 Product News
7.6.1 Jul 02, 2018: Mayo researchers find off/on switch for DNA repair protein
7.6.2 Apr 26, 2018: Integra LifeSciences Debuts Codman Specialty Surgical Extended Portfolio At AANS 2018

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact Us
8.4 Disclaimer

Table 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Neurosurgical Products Market, United States, Volume (Units), 2015-2020
Table 10: Neurosurgical Products Market, United States, Volume (Units), 2021-2025
Table 11: Dura Substitutes Market, United States, Volume (Units), 2015-2020
Table 12: Dura Substitutes Market, United States, Volume (Units), 2021-2025
Table 13: Neuroendoscopes Market, United States, Volume (Units), 2015-2020
Table 14: Neuroendoscopes Market, United States, Volume (Units), 2021-2025
Table 15: Neurosurgical Drills Market, United States, Volume (Units), 2015-2020
Table 16: Neurosurgical Drills Market, United States, Volume (Units), 2021-2025
Table 17: Neurosurgical Products Market, United States, Average Price ($), 2015-2020
Table 18: Neurosurgical Products Market, United States, Average Price ($), 2021-2025
Table 19: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Neurosurgical Products Market Pipeline Products
Table 22: Stryker Raises USD600 Million in Public Offering of 3.65% Notes Due 2028
Table 23: Integra LifeSciences Prices Public Offering of Shares for USD307 Million
Table 24: MRI Interventions Enters into Strategic Agreement with Voyager Therapeutics
Table 25: Shanghai Xianfeng Investment Management to Acquire Elliquence from Alan Ellman for USD77.1 Million
Table 26: Sobera Capital Acquires Equity Holdings in 12 Pharma Companies
Table 27: NeuroPace Raises USD74 Million in Equity Financing
Table 28: Myoscience Raises USD10 Million in Financing
Table 29: Alcyone Lifesciences Raises USD5 Million in Venture Financing
Table 30: MicroTransponder Raises USD11.6 Million in Venture Financing
Table 31: Total Number of Primary Research Participants, Neurology Devices Market, by Country

Figure 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Neurosurgical Products Market, United States, Volume (Units), 2015-2025
Figure 6: Dura Substitutes Market, United States, Volume (Units), 2015-2025
Figure 7: Neuroendoscopes Market, United States, Volume (Units), 2015-2025
Figure 8: Neurosurgical Drills Market, United States, Volume (Units), 2015-2025
Figure 9: Neurosurgical Products Market, United States, Company Share (%) 2017